Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hypoxic tumor cells are cancer cells that exist in regions of a solid tumor where oxygen levels are significantly lower than those found in normal tissues. This hypoxia arises because tumors often outgrow their blood supply, leading to areas with poor oxygenation. These cells exhibit adaptations like activation of hypoxia-inducible factors (HIFs), increased glycolysis, and altered pH regulation. Hypoxia contributes to increased tumor aggressiveness, metastasis, and resistance to chemotherapy and radiotherapy, making hypoxic tumor cells a key target for novel diagnostic and therapeutic strategies.
Inhibition of HIF activity, targeting metabolic adaptations (e.g., glycolysis), selective drug delivery via nanocarriers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hypoxic Tumor Cells.